Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Adenocarcinoma of Endometrium”

111 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 111 results

Not applicableStudy completedNCT01208467
What this trial is testing

Prognostic Biomarkers in Patients With Endometrial Cancer

Who this might be right for
Endometrial AdenocarcinomaRecurrent Uterine Corpus CarcinomaStage I Uterine Corpus Cancer+3 more
Gynecologic Oncology Group 2,824
Testing effectiveness (Phase 2)Study completedNCT00025467
What this trial is testing

Thalidomide in Treating Patients With Recurrent or Persistent Endometrial Cancer

Who this might be right for
Endometrial AdenoacanthomaEndometrial AdenocarcinomaEndometrial Adenosquamous Cell Carcinoma+3 more
National Cancer Institute (NCI) 60
Testing effectiveness (Phase 2)Ended earlyNCT00584909
What this trial is testing

A Phase II Study of Paclitaxel and Carboplatin in Patients With an Elevated-Risk Cancer of the Uterus

Who this might be right for
Uterine Cancer
University of Alabama at Birmingham 13
Not applicableLooking for participantsNCT05655260
What this trial is testing

PErsonalized TReatment for Endometrial Carcinoma

Who this might be right for
Endometrial Adenocarcinoma
University of Helsinki 300
Testing effectiveness (Phase 2)Study completedNCT02697591
What this trial is testing

INCAGN01876 in Participants With Advanced or Metastatic Solid Tumors

Who this might be right for
Advanced MalignanciesMetastatic Cancer
Incyte Biosciences International Sàrl 100
Large-scale testing (Phase 3)Ended earlyNCT00002976
What this trial is testing

Estrogen Replacement Therapy in Treating Women With Early-Stage Endometrial Cancer

Who this might be right for
Endometrial Cancer
Gynecologic Oncology Group 2,108
Early research (Phase 1)WithdrawnNCT04602117
What this trial is testing

ISPY-P1.01:Evaluating the Safety of Weekly Paclitaxel With Trastuzumab Duocarmazine (SYD985) in Patients With Metastatic Cancer

Who this might be right for
HER2-positive Breast CancerHER2 LowSYD-985+24 more
QuantumLeap Healthcare Collaborative
Testing effectiveness (Phase 2)WithdrawnNCT01943058
What this trial is testing

Megestrol Acetate or Levonorgestrel-Releasing Intrauterine System in Treating Patients With Atypical Endometrial Hyperplasia or Endometrial Cancer

Who this might be right for
Atypical Endometrial HyperplasiaEndometrial AdenocarcinomaRecurrent Endometrial Carcinoma+8 more
University of Southern California
Not applicableStudy completedNCT03716414
What this trial is testing

Evaluation of the Efficacy for Sentinel Lymph Node Policy in High-risk Endometrial Carcinoma

Who this might be right for
Endometrial Adenocarcinoma
Fudan University 78
Testing effectiveness (Phase 2)Not Yet RecruitingNCT06066216
What this trial is testing

Cadonilimab (AK104) Plus Chemotherapy in Patients With Recurrent or Advanced Endometrial Cancer

Who this might be right for
Endometrial CancerEndometrial Adenocarcinoma
Fujian Cancer Hospital 45
Not applicableStudy completedNCT07074067
What this trial is testing

V-Notes Hysterectomy in Patients With Endometrial cáncer Compared With Laparoscopic Surgery (Robotically Assisted or Not): ENOLA TRIAL

Who this might be right for
Endometrial Adenocarcinoma
Fundacion para la Formacion e Investigacion Sanitarias de la Region de Murcia 84
Testing effectiveness (Phase 2)Study completedNCT00870337
What this trial is testing

Everolimus in Treating Patients With Relapsed or Metastatic Endometrial Cancer

Who this might be right for
Endometrial Cancer
ARCAGY/ GINECO GROUP 44
Testing effectiveness (Phase 2)WithdrawnNCT03836157
What this trial is testing

Mirvetuximab Soravtansine (IMGN853) and Bevacizumab in Patients With Endometrial Cancer

Who this might be right for
Endometrial CancerEndometrial AdenocarcinomaEndometrial Serous Adenocarcinoma+1 more
University of Oklahoma
Testing effectiveness (Phase 2)Looking for participantsNCT06463028
What this trial is testing

Sapanisertib and Serabelisib (PIKTOR) With Paclitaxel and a Substudy With an Insulin-Suppressing Diet in Patients With Advanced/Recurrent Endometrial Cancer

Who this might be right for
Endometrial Cancer
Faeth Therapeutics 40
Large-scale testing (Phase 3)Study completedNCT00005583
What this trial is testing

Radiation Therapy With or Without Chemotherapy in Treating Patients With High-Risk Endometrial Cancer

Who this might be right for
Endometrial Cancer
Nordic Society of Gynaecological Oncology - Clinical Trials Unit 400
Testing effectiveness (Phase 2)Study completedNCT01210222
What this trial is testing

Trebananib in Treating Patients With Persistent or Recurrent Endometrial Cancer

Who this might be right for
Endometrial AdenocarcinomaEndometrial Adenosquamous CarcinomaEndometrial Clear Cell Adenocarcinoma+4 more
Gynecologic Oncology Group 35
Large-scale testing (Phase 3)Study completedNCT00002493
What this trial is testing

Radiation Therapy Compared With Combination Chemotherapy in Treating Patients With Advanced Endometrial Cancer

Who this might be right for
Endometrial CancerPsychosocial Effects of Cancer and Its Treatment
Gynecologic Oncology Group
Testing effectiveness (Phase 2)Study completedNCT00888173
What this trial is testing

Brivanib Alaninate in Treating Patients With Recurrent or Persistent Endometrial Cancer

Who this might be right for
Endometrial AdenocarcinomaEndometrial Clear Cell AdenocarcinomaEndometrial Mixed Adenocarcinoma+6 more
Gynecologic Oncology Group 45
Testing effectiveness (Phase 2)Study completedNCT00515073
What this trial is testing

Papillary Serous Carcinoma of the Endometrium

Who this might be right for
Endometrial Cancer
M.D. Anderson Cancer Center 30
Testing effectiveness (Phase 2)Study completedNCT01307631
What this trial is testing

Akt Inhibitor MK2206 in Treating Patients With Recurrent or Advanced Endometrial Cancer

Who this might be right for
Endometrial AdenocarcinomaEndometrial Adenosquamous CarcinomaEndometrial Clear Cell Adenocarcinoma+2 more
National Cancer Institute (NCI) 37
Load More Results